This page has been archived on the Web
Information identified as archived is provided for reference, research or recordkeeping purposes. It is not subject to the Government of Canada Web Standards and has not been altered or updated since it was archived. Please contact us to request a format other than those available.
Lamotrigine - 150 mg
- Starting date:
- May 27, 2013
- Posting date:
- June 6, 2013
- Type of communication:
- Drug Recall
- Subcategory:
- Drugs
- Hazard classification:
- Type II
- Source of recall:
- Health Canada
- Issue:
- Product Safety, Quality
- Audience:
- General Public, Healthcare Professionals, Hospitals
- Identification number:
- RA-33943
Recalled products
- Lamotrigine - 150 mg
Reason
Quality concerns at the manufacturing facility of the active ingredients used in the products.
Depth of distribution
Distributed to wholesalers / pharmacies across Canada
Affected products
A. Lamotrigine - 150 mg
DIN, NPN, DIN-HIM
DIN 02343037
Dosage form
- Tablets
Strength
- 150 mg
Lot or serial number
- 36278R
- 1053182
- 1053183
- 1066562
- 3000518
- 3000519
- 3000520
Companies
- Recalling Firm
-
Sanis Health Inc.
333 Champlain Street, Suite 102
Dieppe
E1A 1P2
New Brunswick
CANADA
- Marketing Authorization Holder
-
Sanis Health Inc.
333 Champlain Street, Suite 102
Dieppe
E1A 1P2
New Brunswick
CANADA